Health - Psilocybin's effects on cognition - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > VARIOUS DRUGS > Magic Mushrooms (Psilocybe & Amanita) > Magic Mushroom use
Register Tags Mark Forums Read

Notices

Magic Mushroom use All about using magic mushrooms

Reply
 
Thread Tools Display Modes
  #1  
Old 22-06-2006, 20:34
rxbandit's Avatar
rxbandit Gold member rxbandit is offline
rxbandit has no status.
Chemical Connoisseur
Donating Gold Member
 
Join Date: 19-05-2006
Location: US
Age: 21
Posts: 998
rxbandit must think in IUPACrxbandit must think in IUPACrxbandit must think in IUPACrxbandit must think in IUPACrxbandit must think in IUPACrxbandit must think in IUPACrxbandit must think in IUPACrxbandit must think in IUPACrxbandit must think in IUPACrxbandit must think in IUPACrxbandit must think in IUPAC
Points: 5,674, Level: 11 Points: 5,674, Level: 11 Points: 5,674, Level: 11
Activity: 0% Activity: 0% Activity: 0%
Psilocybin's effects on cognition

Psilocybin's effects on cognition:
Recent research and its implications for enhancing creativity
Matthew J. Baggott
Research Associate, Drug Dependence Research Center
University of California, San Francisco
mbagg@itsa.ucsf.edu
http://itsa.ucsf.edu/~ddrc


For an updated list of psilocybin studies, click here
For Rick Doblin's long-term followup studies to psilocybin research originally conducted or supervised by Timothy Leary at Harvard from 1960-1963, see the Good Friday experiment follow-up, investigating the use of psilocybin in catalyzing mystical experiences, and the Concord Prison experiment follow-up, investigating the use of psilocybin in promoting behavior change and reduced recidivism.
Discussion of the article: Spitzer M, Thimm M, Hermle L, Holzmann P, Kovar KA, Heimann H, Gouzoulis-Mayfrank E, Kischka U, Schneider F (1996); Increased activation of indirect semantic associations under psilocybin. Biol Psychiatry 39:1055-1057. Spitzer and his colleagues have come closer to understanding the effects of psychedelics. As they point out in the conclusion of their paper, they have succeeded in using the results of a simple task to theorize connections between the subjective reports of psychedelic users, objective measures of psilocybin's effects, and underlying brain physiology. In the process they raised a number of productive leads for further research.
The "first wave" of psychedelic research in the 1960s saw many attempts to understand the mechanisms and effects of psychedelics. Looking back on this past research, one gets the idea that psychedelic substances were perhaps too complex for the scientific tools of the time. The current wave of psychedelic research therefore holds much promise. Since the 1960's, we have gained many sophisticated research tools. These tools include neuropsychological tests-simple, repetitive, game-like tasks-which can give valuable insight into how psychedelics affect the mind. Manfred Spitzer, M.D., Ph.D., and his colleagues (1996) recently published a fascinating report on the effects of psilocybin on one such neuropsychological test.
Spitzer's group orally administered 0.2 mg/kg body weight of psilocybin to eight male volunteers in a double-blind, placebo-controlled experiment. They then studied the effects of psilocybin in a word-recognition task. In this task, subjects identify whether a string of characters is a word or not. Past research has found that subjects can identify a word faster if the previous string of characters is a closely related word. For example, subjects can recognize the word "black" more quickly if it has been immediately preceeded by the word "white." This effect is known as semantic priming. In normal subjects, semantic priming occurs only with closely related words. However, indirectly related words ("sweet" and "lemon," for example) produce semantic priming in thought-disordered schizophrenic subjects (Spitzer et al 1993a, 1993b).
Semantic priming
The researchers found that psilocybin slowed the subjects' reaction times while at the same time producing a semantic priming effect for indirectly related words ("sweet" and "lemon"), similar to that seen in the schizophrenia research. The finding that psilocybin slowed reaction times was not unexpected; past research with psychedelics has found the same effect. However, the finding that psilocybin produced indirect semantic priming is more interesting. In their discussion, the researchers point out that their findings are relevant to claims that psychedelics "enhance creativity" or "broaden consciousness":
Although most objective measures have failed to support these claims, our data suggest that the [hallucinogenic] agent in fact leads to an increased availability of remote associations and thereby may bring cognitive contents to mind that under normal circumstances remain nonactivated; however, the generally decreased psychological performance under hallucinogenic agents suggest that the increased indirect priming effect is due to a decreased capacity to use contextual information for the focusing of semantic processing. Hence, subjectively experienced increases in creativity as well as the broadening of consciousness have been found to parallel decreases in objective performance measures (p. 1056-1057).
Thus, the researchers suggest that psychedelics may in fact "broaden consciousness" by making remote mental associations more available. However, this involves a trade-off. Although remote mental associations are more available, subjects are less able to focus, which slows their reaction times.
Semantic neural networks
The researchers interpret their findings using a model which states that the brain contains semantic neural networks which can become activated by semantic information. The spread of this activation through the networks determines the amount of semantic priming that occurs in the word-recognition task. Activation spreads further and faster in thought-disordered schizophrenics and psilocybin users than in normal volunteers. One explanation for this unusual amount of activation is decreased efficiency in the cortex where semantic information is processed (Servan-Schreiber et al 1990, Cohen and Servan-Schreiber 1992, 1993). There is evidence that this inefficient processing is related to the decreased dopaminergic modulation. In support of this theory, the researchers have found that L-dopa, a precursor to dopamine, reduces the spread of activation and therefore reduces indirect semantic priming (Kischka et al 1995). In the context of this theory, psilocybin (which acts on the serotonin system) can be seen as increasing activation of semantic networks. Essentially, dopamine seems to have a focusing effect on activation of semantic networks while psilocybin has a defocusing effect.
Word-recognition task
The word-recognition task used by Spitzer's group is particularly interesting for a number of reasons. First, it allows researchers to test automatic rather than voluntary access to memory. Even when subjects cannot consciously recall previously viewed words (whether because of a drug or neurological disorder), the word-recognition task can demonstrate whether subjects can still automatically access that memory. In addition, the task allows researchers to see how the focus of subjects' mental associations is changed by different pharmacological or psychological states. This aspect seems potentially promising for distinguishing between different types of memories. For example, in some situations, emotional words ("happy" and "sad") might be activated to a greater extent than words with little emotional content ("black" and "white").
Spitzer and his colleagues have come closer to understanding the effects of psychedelics. As they point out in the conclusion of their paper, they have succeeded in using the results of a simple task to theorize connections between the subjective reports of psychedelic users, objective measures of psilocybin's effects, and underlying brain physiology. In the process they raised a number of productive leads for further research.
References
  1. Cohen JD, Servan-Schreiber D (1992); Context, cortex and dopamine: A connectionist approach to behavior and biology in schizophrenia. Psychol Rev 12:45-77.
  2. Cohen JD, Servan-Schreiber D (1993); A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizoph Bull 19:85-104.
  3. Kischka U, Kammer T, Weisbrod M, Maier S, Thimm M, Spitzer M (1995); Dopaminergic modulation of semantic network activation (in submission). Servan-Schreiber D, Printz H, Cohen JD (1990); A network model of catcholamine effects: Gain, signal-to-noise ratio, and behavior. Science 249:892-895.
  4. Spitzer M, Braun U, Maier S, Hermle L, Maher BA (1993a); Indirect semantic priming in schizophrenic patients. Schizoph Res 11:71-80.
  5. Spitzer M, Braun U, Hermle L, Maier S (1993b); Associative semantic network dysfunction in thought-disordered schizophrenic patients: Direct evidence from indirect semantic priming. Biol Psychiatry 34:864-877.
  6. Spitzer M, Thimm M, Hermle L, Holzmann P, Kovar KA, Heimann H, Gouzoulis-Mayfrank E, Kischka U, Schneider F (1996); Increased activation of indirect semantic associations under psilocybin. Biol Psychiatry 39:1055-1057.
Reply With Quote
Reply

Bookmarks

Tags
psilocybin and cognition, psilocybin research, psychedelic research

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Drug info - Low down on some of the most common anti-depressant med's.... Unsolved Antidepressants 21 27-07-2009 06:01
Psychotropic Effects of Dextromethorphan Are Altered by the CYP2D6 Polymorphism Bajeda DXM 13 08-07-2009 02:53
Interesting scholarly drug facts rxbandit Pharmacology 17 30-10-2008 06:53
Legal Herbs and Chemicals OneDiaDem Herbal Ecstasy 35 05-02-2008 07:24
Obesity Drugs and Novel Targets... an EXCELLENT Read... the Future of Anorectics! Richard_smoker Health (News) 9 30-10-2007 07:30


Sitelinks: Site Functions:

All times are GMT +1. The time now is 05:59.


Copyright: Substance Information Network 2003 - 2009, All rights reserved